The Weed Blog has reported news from CannaKids and Saving Sophie in the past, and we are hugely supportive of their efforts.  We feel that organizations such as these will be a big piece of what helps end cannabis prohibition in the United States, and hopefully world wide, ultimately.

CURE Pharmaceutical and CannaKids Announce Collaboration

The Weed Blog has reported news from CannaKids and Saving Sophie in the past, and we are hugely supportive of their efforts.  We feel that organizations such as these will be a big piece of what helps end cannabis prohibition in the United States, and hopefully world wide, ultimately.  Here is the latest from them!

OXNARD, Calif., May 31, 2017 (GLOBE NEWSWIRE) — CURE Pharmaceutical  (CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company, announced today that the CURE and the CannaKids partnership has entered into a strategic research collaboration with Technion Research and Development Foundation Ltd., wholly owned subsidiary of the Technion-Israel Institute of Technology, in order to research how different cannabinoid compounds within cannabis strains can be used to treat various subtypes of cancer.

Researchers from CURE’s Pharmaceutical Cannabinoid Division and Technion’s Laboratory of Cancer Biology and Cannabinoid Research will work together to research and identify how varying cannabinoid compounds within cannabis strains can affect various cancer subtypes. The results of the…

Continue reading at theweedblog.com

About The Weed Blog

Since its inception, TWB has been based in activism and the mobilization and movements for marijuana policy reform happening around the country. It was created for one purpose: to facilitate a constructive conversation about marijuana in America. This includes both medical and recreational marijuana policy, as well as the marijuana industry and culture.

Leave a Reply

Your email address will not be published. Required fields are marked *